A Study to Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healthy Subjects

NCT05974969 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
146
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biocad